Efficacy and Safety of Tofacitinib in Refractory Blau Syndrome
Clinical trial NCT06660329 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06660329
- Sponsor
- Peking Union Medical College Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2027-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.